Top headlines: Economic Survey sees India GDP growing at 11% in FY22

Johnson & Johnson's one-shot vaccine generated strong protection against Covid-19, Tata Motors Q3 profit surges 67%

economic survey, budget, economy
Illustration: Binay Sinha
BS Web Team
2 min read Last Updated : Jan 29 2021 | 7:43 PM IST
Economic survey pegs India's GDP growth at 11% for FY22

India forecast robust economic growth of 11% for the fiscal year beginning on April 1 in its annual economic survey on Friday, on the back of the beginning of a nationwide coronavirus vaccination drive and a rebound in consumer demand. Read here

J&J says vaccine offers strong protection
 
Johnson & Johnson’s one-shot vaccine generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunisation campaign. Read here

Tricolour insulted during farmers' protest: President Kovind

President Ram Nath Kovind on Thursday strongly defended the three contentious agri laws that have sparked intense protests from a section of farmers, and condemned as "'very unfortunate" the Republic Day violence and the "insult" to the tricolour during the farmers' tractor parade here on January 26. Read here

Tata Motors Q3 profit surges 67%
 
Jaguar Land Rover (JLR) owner Tata Motors Ltd on Friday posted a 67.2% surge in profit for the December quarter, as the easing of coronavirus restrictions and the festive season helped the carmaker clock in better sales. Read here

Small investors behind surge in GameStop
 
An army of retail investors that has routed Wall Street's professionals in recent days was dealt a blow on Thursday, after online brokerages restricted trading in red-hot GameStop and other stocks that had soared this week. Read here

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story